Lung Disease News |
New Therapeutic Program Leader to Take Over Asthma, Other Conditions at Knopp …
Lung Disease News Dexpramipexole is an oral, small molecule medicine candidate, currently in development for the treatment of asthma, amyotrophic lateral sclerosis (ALS), and other conditions associated with eosinophils — white blood cells of the immune system … |
View full post on asthma – Google News